These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

402 related items for PubMed ID: 18940913

  • 1. Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins.
    Tang CH, Hill ML, Brumwell AN, Chapman HA, Wei Y.
    J Cell Sci; 2008 Nov 15; 121(Pt 22):3747-56. PubMed ID: 18940913
    [Abstract] [Full Text] [Related]

  • 2. Interleukin-1alpha enhances the aggressive behavior of pancreatic cancer cells by regulating the alpha6beta1-integrin and urokinase plasminogen activator receptor expression.
    Sawai H, Okada Y, Funahashi H, Matsuo Y, Takahashi H, Takeyama H, Manabe T.
    BMC Cell Biol; 2006 Feb 20; 7():8. PubMed ID: 16504015
    [Abstract] [Full Text] [Related]

  • 3. Urokinase-type plasminogen activator receptors associate with beta1 and beta3 integrins of fibrosarcoma cells: dependence on extracellular matrix components.
    Xue W, Mizukami I, Todd RF, Petty HR.
    Cancer Res; 1997 May 01; 57(9):1682-9. PubMed ID: 9135008
    [Abstract] [Full Text] [Related]

  • 4. A new class of orthosteric uPAR·uPA small-molecule antagonists are allosteric inhibitors of the uPAR·vitronectin interaction.
    Liu D, Zhou D, Wang B, Knabe WE, Meroueh SO.
    ACS Chem Biol; 2015 Jun 19; 10(6):1521-34. PubMed ID: 25671694
    [Abstract] [Full Text] [Related]

  • 5. Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.
    Wei Y, Eble JA, Wang Z, Kreidberg JA, Chapman HA.
    Mol Biol Cell; 2001 Oct 19; 12(10):2975-86. PubMed ID: 11598185
    [Abstract] [Full Text] [Related]

  • 6. RhoB regulates uPAR signalling.
    Alfano D, Ragno P, Stoppelli MP, Ridley AJ.
    J Cell Sci; 2012 May 15; 125(Pt 10):2369-80. PubMed ID: 22366462
    [Abstract] [Full Text] [Related]

  • 7. Functional relevance of urinary-type plasminogen activator receptor-alpha3beta1 integrin association in proteinase regulatory pathways.
    Ghosh S, Johnson JJ, Sen R, Mukhopadhyay S, Liu Y, Zhang F, Wei Y, Chapman HA, Stack MS.
    J Biol Chem; 2006 May 12; 281(19):13021-13029. PubMed ID: 16510444
    [Abstract] [Full Text] [Related]

  • 8. ECRG2 regulates cell migration/invasion through urokinase-type plasmin activator receptor (uPAR)/beta1 integrin pathway.
    Cheng X, Shen Z, Yin L, Lu SH, Cui Y.
    J Biol Chem; 2009 Nov 06; 284(45):30897-906. PubMed ID: 19717562
    [Abstract] [Full Text] [Related]

  • 9. Urokinase receptors are required for alpha 5 beta 1 integrin-mediated signaling in tumor cells.
    Wei Y, Tang CH, Kim Y, Robillard L, Zhang F, Kugler MC, Chapman HA.
    J Biol Chem; 2007 Feb 09; 282(6):3929-39. PubMed ID: 17145753
    [Abstract] [Full Text] [Related]

  • 10. Antagonistic anti-urokinase plasminogen activator receptor (uPAR) antibodies significantly inhibit uPAR-mediated cellular signaling and migration.
    Duriseti S, Goetz DH, Hostetter DR, LeBeau AM, Wei Y, Craik CS.
    J Biol Chem; 2010 Aug 27; 285(35):26878-26888. PubMed ID: 20501655
    [Abstract] [Full Text] [Related]

  • 11. Downregulation of urokinase plasminogen activator receptor expression inhibits Erk signalling with concomitant suppression of invasiveness due to loss of uPAR-beta1 integrin complex in colon cancer cells.
    Ahmed N, Oliva K, Wang Y, Quinn M, Rice G.
    Br J Cancer; 2003 Jul 21; 89(2):374-84. PubMed ID: 12865932
    [Abstract] [Full Text] [Related]

  • 12. uPAR regulates pericellular proteolysis through a mechanism involving integrins and fMLF-receptors.
    Montuori N, Cosimato V, Rinaldi L, Rea VE, Alfano D, Ragno P.
    Thromb Haemost; 2013 Feb 21; 109(2):309-18. PubMed ID: 23238745
    [Abstract] [Full Text] [Related]

  • 13. An uncleavable uPAR mutant allows dissection of signaling pathways in uPA-dependent cell migration.
    Mazzieri R, D'Alessio S, Kenmoe RK, Ossowski L, Blasi F.
    Mol Biol Cell; 2006 Jan 21; 17(1):367-78. PubMed ID: 16267271
    [Abstract] [Full Text] [Related]

  • 14. Mannose 6-phosphate/insulin-like growth factor 2 receptor limits cell invasion by controlling alphaVbeta3 integrin expression and proteolytic processing of urokinase-type plasminogen activator receptor.
    Schiller HB, Szekeres A, Binder BR, Stockinger H, Leksa V.
    Mol Biol Cell; 2009 Feb 21; 20(3):745-56. PubMed ID: 19037107
    [Abstract] [Full Text] [Related]

  • 15. Expression of urokinase-type plasminogen activator/urokinase-type plasminogen activator receptor and maspin in oral squamous cell carcinoma: Association with mode of invasion and clinicopathological factors.
    Yoshizawa K, Nozaki S, Kitahara H, Kato K, Noguchi N, Kawashiri S, Yamamoto E.
    Oncol Rep; 2011 Dec 21; 26(6):1555-60. PubMed ID: 21833477
    [Abstract] [Full Text] [Related]

  • 16. Modified Panax ginseng Extract Inhibits uPAR-Mediated α[Formula: see text]β1-Integrin Signaling by Modulating Caveolin-1 to Induce Early Apoptosis in Lung Cancer Cells.
    Hwang IH, Kwon YK, Cho CK, Lee YW, Sung JS, Joo JC, Lee KB, Yoo HS, Jang IS.
    Am J Chin Med; 2016 Dec 21; 44(5):1081-97. PubMed ID: 27430913
    [Abstract] [Full Text] [Related]

  • 17. Critical role of integrin alpha 5 beta 1 in urokinase (uPA)/urokinase receptor (uPAR, CD87) signaling.
    Tarui T, Andronicos N, Czekay RP, Mazar AP, Bdeir K, Parry GC, Kuo A, Loskutoff DJ, Cines DB, Takada Y.
    J Biol Chem; 2003 Aug 08; 278(32):29863-72. PubMed ID: 12754207
    [Abstract] [Full Text] [Related]

  • 18. Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration.
    Yebra M, Parry GC, Strömblad S, Mackman N, Rosenberg S, Mueller BM, Cheresh DA.
    J Biol Chem; 1996 Nov 15; 271(46):29393-9. PubMed ID: 8910604
    [Abstract] [Full Text] [Related]

  • 19. Degradation of internalized αvβ5 integrin is controlled by uPAR bound uPA: effect on β1 integrin activity and α-SMA stress fiber assembly.
    Wang L, Pedroja BS, Meyers EE, Garcia AL, Twining SS, Bernstein AM.
    PLoS One; 2012 Nov 15; 7(3):e33915. PubMed ID: 22470492
    [Abstract] [Full Text] [Related]

  • 20. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR.
    Plesner T, Behrendt N, Ploug M.
    Stem Cells; 1997 Nov 15; 15(6):398-408. PubMed ID: 9402652
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.